Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author response to letter.

Journal of the neurological sciences·2026
Same author

Neutrophil-microglia interaction drives motor dysfunction in a neuromyelitis optica model induced by subarachnoid AQP4-IgG.

The Journal of clinical investigation·2026
Same author

The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of tumefactive demyelination.

Journal of the neurological sciences·2026
Same author

Fourier transform infrared spectroscopy detects distinct TAR DNA-binding protein 43 signatures in frontotemporal lobar degeneration.

Frontiers in neuroscience·2025
Same author

Critical demyelinating lesions in progressive multiple sclerosis: a prospective observational study.

Journal of neurology·2025
Same author

Neutrophil-microglia interaction drives reversible motor dysfunction in neuromyelitis optica model induced by subarachnoid AQP4-IgG.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Apr 30, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K

Pathologic heterogeneity persists in early active multiple sclerosis lesions.

Imke Metz1, Stephen D Weigand, Bogdan F G Popescu

  • 1Department of Neuropathology, University Medical Center, Georg August University, Göttingen, Germany.

Annals of Neurology
|April 29, 2014
PubMed
Summary

Multiple sclerosis (MS) lesions show consistent immunopathological patterns over time within individual patients, supporting patient-specific disease mechanisms. This suggests tailored therapies may be beneficial for different patient subgroups.

More Related Videos

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

6.5K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.0K

Related Experiment Videos

Last Updated: Apr 30, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

6.5K
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

5.0K

Area of Science:

  • Neuropathology
  • Immunohistochemistry
  • Demyelinating Diseases

Background:

  • Multiple sclerosis (MS) lesions exhibit diverse immunopathological patterns of demyelination.
  • Previous studies suggested lesions within one patient are similar, while patterns vary between patients.
  • The possibility of time-dependent changes in lesion pathology has also been proposed.

Purpose of the Study:

  • To investigate the temporal stability of demyelination immunopatterns in multiple sclerosis.
  • To determine if lesion patterns persist over time within the same individual.

Main Methods:

  • Analysis of archival central nervous system tissue samples from patients with inflammatory demyelinating disease.
  • Immunohistochemical examination of serial biopsies or biopsy-autopsy samples from 22 MS patients.
  • Inclusion criteria required early active demyelinating lesions from the same patient at multiple time points.

Main Results:

  • Ninety-five percent (21/22) of patients demonstrated consistent immunopathological patterns across different time points.
  • This persistence was observed for all major demyelination patterns studied.
  • One patient showed transient mixed patterns, with a predominant pattern at autopsy.

Conclusions:

  • Findings support the concept of patient-specific immunopathological heterogeneity in early MS.
  • Suggests distinct tissue injury mechanisms and targets may exist across patient subgroups.
  • Highlights potential for individualized therapeutic strategies in MS management.